Global Breast Lesion Localization Market 2023-2030

Description

List of Tables

The global breast lesion localization market size was valued at $480 million in 2022, and is projected to reach $812 million by 2030, registering a CAGR of 7.8% during the forecast period (2023-2030). The global breast lesion localization market is expected to witness significant growth during the forecast period due to rising prevalence of breast cancer across the globe. Early detection of the malignancy of palpable and non-palpable breast lesions can result in effective and timely treatment of various breast abnormalities. One-third of breast cancers diagnosed each year globally are subtle, and this level rises as screening programs become more prevalent and more advanced modalities such as MRI detect more clinically potential lesions. It is a safe and accurate non-surgical method for diagnosing suspicious abnormal findings in breast images and is essential for proper decision making, including treatment planning. The rising incidence of breast cancer is creating awareness about the disease among women which is expected to contribute to the growth of the market. Further, the rise in the number of screening and imaging techniques in the market is also expected to propel the market growth.

Segmental Outlook:

The global breast lesion localization market is segmented based on the type and usage. Based on the type, the market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization. Based on the usage, the market is further sub-segmented into breast biopsy, breast conservation (lumpectomy), and others. Among the usage, the breast conservation is expected to hold considerable share in the market over the forecast period owing to factors such as the rising number of breast cancer among the women globally.

The Wire Localization Sub-Segment is anticipated to Hold Prominent Share in the Global Breast Lesion Localization Market

The wire localization segment is expected to witness significant growth in the breast lesion localization systems market over the forecast period owing to factors such as the rising prevalence of breast cancer among the population, growing technologically advanced products, and rising product launches. The advantages offered by the wire localization method, such as being less expensive, more accurate, and more effective than other breast lesion localization techniques, are also expected to increase its adoption during breast cancer treatment. This factor is also expected to impact the growth of the segment positively.

Regional Outlooks:

The global breast lesion localization market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to hold significant share in the market growth over the forecast period owing to the factors such as market players are taking strategic initiatives on widening product portfolio, diversified business operations, lower costs, user satisfaction, and improve breast lesion localization Methods reliability.

The North America Region Is Expected To Hold Prominent Share in the Global Breast Lesion Localization Market

North America is expected to hold a prominent share in the market over the forecast period. The factors such as rising burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer are propelling the growth of the breast lesion localization market. The rising breast cancer cases rise the demand for diagnostics and surgical procedures for treating breast cancer which will contribute to the breast lesion localization market over the years. Furthermore, the rising product approvals in the region increase the availability of localization devices in the market which is anticipated to boost market growth over the forecast period.

Market Players Outlook:

The major companies serving the global breast lesion localization market include Argon Medical Devices, Matek Medical Devices Technology Industry and Trade Inc., Sterylab S.R.L., Medax Medical Devices, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Merit Medical System enrolled the first patient in a post-market, observational study to demonstrate the benefits of SCOUT, a wireless, radar-guided localization system for marking breast tumors, biopsy sites, and lymph nodes.

Product Code: OMR2023832

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Breast Lesion Localization Market by Type
- 4.1.1. Wire Localization
- 4.1.2. Radioisotope Localization
- 4.1.3. Magnetic Localization
- 4.1.4. Electromagnetic Localization
- 4.1.5. Other Localization
4.2. Global Breast Lesion Localization Market by Usage
- 4.2.1. Breast Biopsy
- 4.2.2. Breast Conservation (Lumpectomy)
- 4.2.3. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Argon Medical Devices
6.2. Becton, Dickinson and Co.
6.3. Biomedical S.R.L
6.4. Biopsybell S.R.L.
6.5. C.R. Bard, Inc.
6.6. CP Medical
6.7. Devicor Medical Products Inc.
6.8. Endomagnetics Ltd.
6.9. Hologic Inc.
6.10. IsoAid
6.11. Leica Biosystems Nussloch GmbH
6.12. Matek Medical Devices Technology Industry and Trade Inc.
6.13. MDL SRL
6.14. Medax Medical Devices
6.15. Merit Medical Systems, Inc.
6.16. Mermaid Medical A/S
6.17. Molli Surgical Inc.
6.18. Ranfac Corp.
6.19. Sirius Medical Systems B.V.
6.20. Sterylab S.R.L.
6.21. SurgicEye GmbH
6.22. Tsunami Medical S.R.L.
6.23. Vigeo S.R.L.